TGFB1 and neoplasm: In contrast, mutated TGF-β signaling can prompt tumor invasiveness and metastasis at a late stage of tumorigenesis by activating angiogenesis, migration, invasion and epithelial-mesenchymal transition (EMT) [7, 8].